Noah Goldfarb, MD, FAAD
SESSIONS
F013 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 8, 2024
•
9:00 AM - 11:00 AM
•
Room 1B
DISCLOSURES
AbbVie – Investigator(No Compensation Received); Boehringer Ingelheim – Consultant(Fees); ChemoCentryx – Investigator(No Compensation Received); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(No Compensation Received); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees);